Treatment of cutaneous lymphoid hyperplasia with thalidomide: Report of two cases

Journal of the American Academy of Dermatology

Volumn 40, Issue 6 I, 1999, Pages 1005-1007

  Benchikhi, H ^a   Bodemer, C ^a   Fraitag, S ^a   Wechsler, J ^a   Delfau Larue, M H ^a   Gounod, N ^a   De Prost, Y ^a   Revuz, J ^a   Bagot, M ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

ADOLESCENT; ADULT; ARTICLE; B CELL LYMPHOMA; CASE REPORT; DISEASE COURSE; FACE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOID HYPERPLASIA; MALE; NOSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOLYMPHOMA; REMISSION; SKIN BIOPSY; SKIN LYMPHOMA; TREATMENT OUTCOME;

EID: 0033067221     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70094-0     Document Type: Article

References (11)

1. T Ploysangam DL Breneman DF. Mutasim Cutaneous pseudolymphomas J Am Acad Dermatol 38 1998 877 905
2. JU Rijlaarsdam R. Willemze Cutaneous pseudolymphomas: classification and differential diagnosis Semin Dermatol 13 1994 187 196
3. GS Wood BY Ngan R Tung TE Hoffman EA Abel RT Hoppe Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia Am J Pathol 135 1989 13 19
4. S Tseng G Pak K Washenik MK Pomeranz JL. Shupack Rediscovering thalidomide: a review of its mechanisms of action, side effects, and potential uses J Am Acad Dermatol 35 1996 969 979
5. JM Jacobson JS Greenspan J Spritzler N Ketter JL Fahey JB Jackson Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection N Engl J Med 336 1997 1487 1493
6. RJ Stevens C Andujar CJ Edwards PR Ames AR Barwick MA Khamashta Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients Br J Rheumatol 36 1997 353 359
7. EP Sampaio EN Sarno R Galilly ZA Cohn G. Kaplan Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes J Exp Med 173 1991 699 703
8. D Charue E Chauvin C Duguet J Revuz M. Bagot Thalidomide decreases the production of GM-CSF and TNF-alpha in the mixed epidermal cell-lymphocyte reaction Eur J Dermatol 6 1996 373 376
9. DR Moller M Wysocka BM Greenlee X Ma L Wahl DA Flockhart Inhibition of IL-12 production by thalidomide J Immunol 159 1997 5157 5161
10. JC Guillaume G Moulin MT Dieng F Poli P Morel P Souteyrand Crossover study of thalidomide vs placebo in Jessner’s lymphocytic infiltration of the skin Arch Dermatol 131 1995 1032 1035
11. S Ochonisky J Verroust S Bastuji-Garin R Gherardi J. Revuz Thalidomide neuropathy incidence and clinicoelectrophysiologic findings in 42 patients Arch Dermatol 130 1994 66 69